The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2007 AND VI 46 AND IP 4
Results: 8
1
2
Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.
- Published in:
- 2007
- By:
- Publication type:
- journal article
3
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.
- Published in:
- 2007
- By:
- Publication type:
- journal article
4
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
- Published in:
- 2007
- By:
- Publication type:
- journal article
5
Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury.
- Published in:
- 2007
- By:
- Publication type:
- journal article
6
Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
7
The Clinical Pharmacokinetics of Escitalopram.
- Published in:
- Clinical Pharmacokinetics, 2007, v. 46, n. 4, p. 281, doi. 10.2165/00003088-200746040-00002
- By:
- Publication type:
- Article
8
The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs.
- Published in:
- Clinical Pharmacokinetics, 2007, v. 46, n. 4, p. 271, doi. 10.2165/00003088-200746040-00001
- By:
- Publication type:
- Article